| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2011 | US20110003780 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
| 01/06/2011 | US20110003779 15, 16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative , use thereof, and medicament containing said derivative |
| 01/06/2011 | US20110003778 Mineralcorticoid receptor antagonists for the treatment of endometriosis |
| 01/06/2011 | US20110003777 Methods of Treatment Employing Prolonged Continuous Infusion of Belinostat |
| 01/06/2011 | US20110003776 Tetrahydropyranonaphthyridines derivatives, pharmaceutical compositions and therapeutic treatment thereof |
| 01/06/2011 | US20110003775 Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder |
| 01/06/2011 | US20110003774 Compounds having anti-proliferative properties |
| 01/06/2011 | US20110003773 Using fullerenes to enhance and stimulate hair growth |
| 01/06/2011 | US20110003772 Use of sphingolipids in the treatment of type 2 diabetes mellitus, insulin resistance and metabolic syndrome |
| 01/06/2011 | US20110003771 Wood Preservative Composition |
| 01/06/2011 | US20110003770 Method and pharmaceutical to treat spinal discs |
| 01/06/2011 | US20110003769 Anti-aging composition for external use comprising low and high molecular weight hyaluronic acids and the polysaccharides extracted from root bark of ulmus davidiana |
| 01/06/2011 | US20110003768 Prebiotic compositions |
| 01/06/2011 | US20110003767 Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism |
| 01/06/2011 | US20110003766 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2ar agonists |
| 01/06/2011 | US20110003765 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 01/06/2011 | US20110003764 Methods for Treatment of HIV or Malaria Using Combinations of Chloroquine and Protease Inhibitors |
| 01/06/2011 | US20110003763 Avermectin/benzoyl peroxide compositions for treating afflictions of the skin, e.g., rosacea |
| 01/06/2011 | US20110003762 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| 01/06/2011 | US20110003761 Biologically active extract from dendrobium plant, use thereof and process for preparing the same |
| 01/06/2011 | US20110003760 Abnormal protein removing method |
| 01/06/2011 | US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/06/2011 | US20110003758 Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors |
| 01/06/2011 | US20110003757 Pharmaceutical compositions for treating fatty liver disease |
| 01/06/2011 | US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof |
| 01/06/2011 | US20110003747 Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| 01/06/2011 | US20110003742 Naphthalimide Dosing by N-Acetyl Transferase Genotyping |
| 01/06/2011 | US20110003740 Insulin sensitisers and methods of treatment |
| 01/06/2011 | US20110003739 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003734 Proteins and polynucleotides of vibrio cholerae |
| 01/06/2011 | US20110003689 Use of polymeric guanidine derivatives for the control of unwanted microorganisms in crop protection |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003307 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 01/06/2011 | US20110003020 Topical compositions for anti-aging and methods of using same |
| 01/06/2011 | US20110003016 Hair care composition |
| 01/06/2011 | US20110003013 Method of increasing metabolism |
| 01/06/2011 | US20110003012 Treating patients with subarachnoid hemorrhage |
| 01/06/2011 | US20110003010 Phosphoric Acid Esters Containing Phosphorus Atoms Bridged By Diol Units |
| 01/06/2011 | US20110003007 Microparticle and pharmaceutical composition thereof |
| 01/06/2011 | US20110003006 Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics |
| 01/06/2011 | US20110003005 Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| 01/06/2011 | US20110003001 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| 01/06/2011 | US20110003000 Transvaginal Delivery of Drugs |
| 01/06/2011 | US20110002999 Biopolymer System for Tissue Sealing |
| 01/06/2011 | US20110002997 Photoinitiated tissue filler |
| 01/06/2011 | US20110002995 Pharmaceutical composition for the treatment and prevention of cardiac disease |
| 01/06/2011 | US20110002993 Film coated tablets containing drospirenone as active agent and a method for the preparation thereof |
| 01/06/2011 | US20110002992 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 01/06/2011 | US20110002991 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof |
| 01/06/2011 | US20110002990 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 01/06/2011 | US20110002989 Methods, dosage forms and kits for administering ziprasidone without food |
| 01/06/2011 | US20110002988 Orally rapidly disintegrating tablet comprising imidafenacin |
| 01/06/2011 | US20110002987 Nicorandil Carriers with Enhanced Stability |
| 01/06/2011 | US20110002985 Abuse resistant drugs, method of use and method of making |
| 01/06/2011 | US20110002982 Lipid carrier compositions with enhanced blood stability |
| 01/06/2011 | US20110002981 MCPIP Protection Against Cardiac Dysfunction |
| 01/06/2011 | US20110002980 Vaccines using nucleic acid-lipid complexes |
| 01/06/2011 | US20110002979 Styrene maleic anhydride based formulation for male contraception and prostate cancer |
| 01/06/2011 | US20110002977 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 01/06/2011 | US20110002976 Medicated patch |
| 01/06/2011 | US20110002975 Preoperative treatment of post operative pain |
| 01/06/2011 | US20110002967 Methods of Transdermally Administering an Indole Serotonin Receptor Agonist and Transdermal Compositions for Use in the Same |
| 01/06/2011 | US20110002965 Immunomodulating compounds and related compositions and methods |
| 01/06/2011 | US20110002963 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/06/2011 | US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002947 Leptomycin derivatives |
| 01/06/2011 | US20110002946 Immunostimulatory Combinations |
| 01/06/2011 | US20110002944 Compositions and Methods to Promote Neural Cell Growth |
| 01/06/2011 | US20110002940 Pathways involved in arteriogenesis and uses thereof |
| 01/06/2011 | US20110002928 Uses of Mammalian Cytokine; Related Reagents |
| 01/06/2011 | US20110002923 Methods of inhibiting tumor growth using ttk antagonists |
| 01/06/2011 | US20110002918 Methods of treating diseased tissue |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002907 Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility |
| 01/06/2011 | US20110002905 Compositions of fat-soluble active ingredients containing protein-polysaccharide conjugates |
| 01/06/2011 | US20110002900 Medium chain dicarboxylic acids, their derivates and metabolic disorders |
| 01/06/2011 | US20110002896 Methods and related compositions for reduction of fat |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/06/2011 | US20110002893 Diagnosis and treatment of congenital heart defects using nell1 |
| 01/06/2011 | US20110002892 Modular aptamar-regulated ribozymes |
| 01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
| 01/06/2011 | US20110002886 Tetrahydrofuro [3,4-d] dioxolane compounds for use in the treatment of viral infections and cancer |
| 01/06/2011 | US20110002884 Therapeutic compounds |
| 01/06/2011 | US20110002881 Treatment and prophylaxis |
| 01/06/2011 | US20110002879 Combinations of Pyrazole Kinase Inhibitors |
| 01/06/2011 | US20110002877 PTEN Inhibitors Treat Neutropenia-Associated Pneumonia |
| 01/06/2011 | US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties |
| 01/06/2011 | US20110002875 Method for treating amyloidosis |
| 01/06/2011 | US20110002868 Cationic synthetic polymers with improved solubility and performance in surfactant-based systems and use in personal care and household applications |
| 01/06/2011 | US20110002866 Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent |
| 01/06/2011 | US20110002865 Moisturizing cosmetic composition comprising a combination of homarine and erythritol |
| 01/06/2011 | US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
| 01/06/2011 | US20110002851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases |